2-nitro-1-N-phenylbenzene-1,4-diamine | CAS:2784-89-6

We serve 2-nitro-1-N-phenylbenzene-1,4-diamine CAS:2784-89-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-nitro-1-N-phenylbenzene-1,4-diamine

Chemical Name:2-nitro-1-N-phenylbenzene-1,4-diamine
CAS.NO:2784-89-6
Synonyms:4-amino-2-nitrodiphenylamine
1,4-Benzenediamine,2-nitro-N1-phenyl
HC Red no. 1; 2-nitro-4-amino-N-phenylaniline
2-Nitro-N1-phenyl-1,4-benzenediamine;
Molecular Formula:C12H11N3O2
Molecular Weight:229.23500
 
Physical and Chemical Properties:
Density:1.351;
Melting point:228-231oC;
Boiling point:417.6oC;
Flash point:206oC;
Index of Refraction:1.711;
 
Specification:
Appearance:Red-brown crystalline powder
Purity(HPLC):≥99.0%
Ash:≤0.5%
Loss on drying:≤0.5%
Fe content:≤50ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 2-nitro-1-N-phenylbenzene-1,4-diamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Nitro-N1-phenyl-1,4-benzenediamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Nitro-N1-phenyl-1,4-benzenediamine Use and application,2-Nitro-N1-phenyl-1,4-benzenediamine technical grade,usp/ep/jp grade.


Related News: “We believe such actions are our last resort,” the Hospital Authority Employees Alliance, a union that formed during the city’s antigovernment protest movement, wrote in a statement.N-(4-Cyanophenyl)guanidine hydrochloride manufacturer “We believe such actions are our last resort,” the Hospital Authority Employees Alliance, a union that formed during the city’s antigovernment protest movement, wrote in a statement.5-Chlorothiophene-2-carbonyl chloride supplier Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.4-(trifluoromethyl)phenol vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.